Research conducted in Japan has reported that statins used for the control of blood lipid levels reduced the transcription of AML-1A, a MIP-1α transcription factor (26), suggesting there are many associations between serum lipid levels and AML prognosis that are worth exploring. The gene discussed is CCL3; the disease is acute myeloid leukemia.